There are 449 resources available
New pathways including FGFR
Presenter: Noemi Reguart Aransay
Session: New biomarkers in NSCLC beyond immunotherapy
Resources:
Slides
Webcast
Biology of STK11 and KEAP1 in NSCLC
Presenter: Antonio Calles Blanco
Session: New biomarkers in NSCLC beyond immunotherapy
Resources:
Slides
Webcast
Case presentation
Presenter: Francesco Cortiula
Session: CNS mets: Oncogene addicted and non-oncogene addicted
Resources:
Slides
Webcast
Beyond G12C: Other RAS / RAF mutation in NSCLC
Presenter: Sanjay Popat
Session: New biomarkers in NSCLC beyond immunotherapy
Resources:
Slides
Webcast
Immunotherapy and targeted therapy options for NSCLC brain metastases
Presenter: Lizza Hendriks
Session: CNS mets: Oncogene addicted and non-oncogene addicted
Resources:
Slides
Webcast
Q&A and discussion
Session: New biomarkers in NSCLC beyond immunotherapy
Resources:
Webcast
Integration of local therapy into systemic treatment for NSCLC brain metastases
Presenter: Antonin Levy
Session: CNS mets: Oncogene addicted and non-oncogene addicted
Resources:
Webcast
Q&A and discussion
Session: CNS mets: Oncogene addicted and non-oncogene addicted
Resources:
Webcast
Is it time to individualise lung cancer screening?
Presenter: Sebastien Couraud
Session: Screening, vaping and smoking cessation: Is it worth it?
Resources:
Slides
Webcast
ADCs in Thoracic Oncology: Current Standards and Lessons Learned
Presenter: Egbert Smit
Session: ADCs: The new promising therapy?
Resources:
Slides
Webcast